AMY WILLIAMS: Open Payments
NPI 1851772867 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$267 in 11 payments from 8 companies in 2025. Trend: 2023 $142 · 2024 $300 · 2025 $267
Food & beverage: $267
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $76 |
| Novartis Pharmaceuticals Corporation | 2 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
| Dexcom, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| SHIELD THERAPEUTICS INC | 1 | $18 |
| Organon LLC | 1 | $16 |
Products named: EPKINLY, KISQALI, ALUNBRIG, DEXCOM G7 GSS (161), JARDIANCE, AIRSUPRA, ACCRUFER, VTAMA.
Industry payments across GA — which companies pay providers there.
